Primary |
Attention Deficit/hyperactivity Disorder |
65.3% |
Product Used For Unknown Indication |
11.3% |
Dermatitis Atopic |
4.7% |
Hypertension |
3.3% |
Tension Headache |
3.3% |
Depression |
2.7% |
Contraception |
2.0% |
Asthma |
1.3% |
Pyrexia |
1.3% |
Abnormal Behaviour |
0.7% |
Conduct Disorder |
0.7% |
Ill-defined Disorder |
0.7% |
Nasopharyngitis |
0.7% |
Personality Disorder |
0.7% |
Rhinitis Allergic |
0.7% |
Vasculitis |
0.7% |
|
Myocardial Infarction |
14.1% |
Appendicitis |
12.5% |
Vomiting |
7.8% |
Completed Suicide |
6.3% |
Restlessness |
6.3% |
Vith Nerve Paralysis |
6.3% |
Drug Exposure During Pregnancy |
4.7% |
Peritonitis |
4.7% |
Bruxism |
3.1% |
Drug Exposure Before Pregnancy |
3.1% |
Dyspnoea |
3.1% |
Electrocardiogram Qt Prolonged |
3.1% |
Hallucination |
3.1% |
Hepatic Function Abnormal |
3.1% |
Hypertension |
3.1% |
Hyperthyroidism |
3.1% |
Irritability |
3.1% |
Loss Of Consciousness |
3.1% |
Mallory-weiss Syndrome |
3.1% |
Overdose |
3.1% |
|
Secondary |
Attention Deficit/hyperactivity Disorder |
44.9% |
Product Used For Unknown Indication |
15.8% |
Drug Use For Unknown Indication |
8.1% |
Dermatitis Atopic |
6.9% |
Poisoning Deliberate |
4.0% |
Obsessive-compulsive Disorder |
3.6% |
Personality Disorder |
3.6% |
Asthma |
2.4% |
Pyrexia |
2.4% |
Suicide Attempt |
1.6% |
Rhinitis Allergic |
1.2% |
Convulsion |
0.8% |
Depression |
0.8% |
Ill-defined Disorder |
0.8% |
Migraine |
0.8% |
Tic |
0.8% |
Anxiety |
0.4% |
Complex Partial Seizures |
0.4% |
Insomnia |
0.4% |
|
Vomiting |
13.6% |
Thyroiditis |
10.2% |
Myocardial Infarction |
9.1% |
Vith Nerve Paralysis |
9.1% |
Hepatic Function Abnormal |
8.0% |
Overdose |
6.8% |
Suicide Attempt |
5.7% |
Appendicitis |
4.5% |
Hallucination |
4.5% |
Restlessness |
4.5% |
Tic |
3.4% |
Decreased Appetite |
2.3% |
Electrocardiogram Qt Prolonged |
2.3% |
Hyperthyroidism |
2.3% |
Intentional Drug Misuse |
2.3% |
Schizophrenia |
2.3% |
Suicidal Ideation |
2.3% |
Thought Broadcasting |
2.3% |
Verbal Abuse |
2.3% |
Weight Increased |
2.3% |
|
Concomitant |
Attention Deficit/hyperactivity Disorder |
24.9% |
Drug Use For Unknown Indication |
23.7% |
Parkinson's Disease |
10.6% |
Depression |
4.9% |
Peyronie's Disease |
3.3% |
Affective Disorder |
2.9% |
Anxiety |
2.9% |
Asthma |
2.4% |
Cognitive Disorder |
2.4% |
Hypertension |
2.4% |
Product Used For Unknown Indication |
2.4% |
Psoriasis |
2.4% |
Tourette's Disorder |
2.4% |
Bipolar Disorder |
2.0% |
Insomnia |
2.0% |
Sleep Disorder |
2.0% |
Blood Cholesterol Increased |
1.6% |
Musculoskeletal Pain |
1.6% |
Tic |
1.6% |
Autism |
1.2% |
|
Weight Increased |
14.3% |
Withdrawal Syndrome |
12.2% |
Aggression |
8.2% |
Drug Ineffective |
8.2% |
Suicide Attempt |
8.2% |
Tic |
8.2% |
Sydenham's Chorea |
6.1% |
Incorrect Dose Administered |
4.1% |
Tremor |
4.1% |
Weight Decreased |
4.1% |
White Blood Cell Count Decreased |
4.1% |
Abnormal Dreams |
2.0% |
Back Pain |
2.0% |
Blood Prolactin Increased |
2.0% |
Breast Cancer |
2.0% |
Convulsion |
2.0% |
Decreased Appetite |
2.0% |
Device Related Infection |
2.0% |
Drug Effect Decreased |
2.0% |
Drug Level Decreased |
2.0% |
|
Interacting |
Attention Deficit/hyperactivity Disorder |
29.2% |
Drug Use For Unknown Indication |
25.0% |
Product Used For Unknown Indication |
20.8% |
Obsessive-compulsive Disorder |
16.7% |
Compulsions |
4.2% |
Tic |
4.2% |
|
Syncope |
30.0% |
Psychotic Disorder |
20.0% |
Tic |
20.0% |
Condition Aggravated |
10.0% |
Drug Interaction |
10.0% |
Dyskinesia |
10.0% |
|